Tada T, et al. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv. 2012;5(3):381–91.

Article  CAS  PubMed  Google Scholar 

Giustino G, et al. Efficacy and safety of dual antiplatelet therapy after complex PCI. J Am Coll Cardiol. 2016;68(17):1851–64.

Article  CAS  PubMed  Google Scholar 

Valgimigli M, et al. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis. Eur Heart J. 2022;43(33):3100–14.

Article  PubMed  Google Scholar 

Gragnano F, et al. P2Y(12) inhibitor monotherapy or dual antiplatelet therapy after complex percutaneous coronary interventions. J Am Coll Cardiol. 2023;81(6):537–52.

Article  CAS  PubMed  Google Scholar 

Baber U, et al. Coronary thrombosis and major bleeding after PCI With drug-eluting stents: risk scores from PARIS. J Am Coll Cardiol. 2016;67(19):2224–34.

Article  PubMed  Google Scholar 

Natsuaki M, et al. Prediction of thrombotic and bleeding events after percutaneous coronary intervention: CREDO-Kyoto thrombotic and bleeding risk scores. J Am Heart Assoc. 2018;7(11): e008708.

Article  PubMed  PubMed Central  Google Scholar 

Ishida M, et al. Clinical outcomes of patients treated using very short duration dual antiplatelet therapy after implantation of biodegradable-polymer drug-eluting stents: rationale and design of a prospective multicenter REIWA registry. Cardiovasc Interv Ther. 2020;35(4):398–404.

Article  CAS  PubMed  Google Scholar 

Ishida M, et al. One-month dual antiplatelet therapy followed by P2Y(12) inhibitor monotherapy after biodegradable polymer drug-eluting stent implantation—the REIWA region-wide registry. Circ J. 2024;88(6):876–84.

Article  PubMed  Google Scholar 

Nakamura M, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J. 2020;84(5):831–65.

Article  PubMed  Google Scholar 

Yamamoto K, et al. Very short dual antiplatelet therapy after drug-eluting stent implantation in patients who underwent complex percutaneous coronary intervention: insight from the STOPDAPT-2 trial. Circ Cardiovasc Interv. 2021;14(5): e010384.

Article  PubMed  Google Scholar 

Watanabe H, et al. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial. JAMA. 2019;321(24):2414–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JM, et al. Intravascular imaging-guided or angiography-guided complex PCI. N Engl J Med. 2023;388(18):1668–79.

Article  PubMed  Google Scholar 

Hahn JY, et al. Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial. JAMA. 2019;321(24):2428–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iglesias JF, et al. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Lancet. 2019;394(10205):1243–53.

Article  CAS  PubMed  Google Scholar 

Buccheri S, et al. Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry. EuroIntervention. 2018;14(5):e562–9.

Article  PubMed  Google Scholar 

Rab T, et al. Current Interventions for the left main bifurcation. JACC Cardiovasc Interv. 2017;10(9):849–65.

Article  PubMed  Google Scholar 

Tobe A, et al. Ischemic and bleeding outcomes in patients who underwent percutaneous coronary intervention with chronic kidney disease or dialysis (from a Japanese nationwide registry). Am J Cardiol. 2023;195:37–44.

Article  PubMed  Google Scholar 

Faggioni M, et al. Influence of baseline anemia on dual antiplatelet therapy cessation and risk of adverse events after percutaneous coronary intervention. Circ Cardiovasc Interv. 2019;12(4): e007133.

Article  PubMed  Google Scholar 

Costa F, et al. A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making. Am Heart J. 2020;223:44–7.

Article  CAS  PubMed  Google Scholar 

Han JK, et al. Renal function-stratified comparison of short- and long-term dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with third-generation drug-eluting stents- post hoc analysis from the HOST-IDEA randomized clinical trial. Circ J. 2024. https://doi.org/10.1253/circj.CJ-24-0481.

Article  PubMed  Google Scholar 

Watanabe H, et al. Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial. Cardiovasc Interv Ther. 2021;36(1):91–103.

Article  PubMed  Google Scholar 

Perera D, et al. Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. 2022;387(15):1351–60.

Article  PubMed  Google Scholar 

Velazquez EJ, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374(16):1511–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mebazaa A, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400(10367):1938–52.

Article  CAS  PubMed  Google Scholar 

Aguilar-Gallardo JS, Correa A, Contreras JP. Cardio-renal benefits of sodium-glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence. Eur Heart J Cardiovasc Pharmacother. 2022;8(3):311–21.

Article  PubMed  Google Scholar 

Anand IS, Gupta P. Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation. 2018;138(1):80–98.

Article  CAS  PubMed  Google Scholar